FDA Inspection
Haupt Pharma Berlin GmbHHaupt Pharma Berlin GmbH – FDA Inspection, Jan 15, 2016
Record Details
This FDA Inspection record concerns Haupt Pharma Berlin GmbH, with an inspection on January 15, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Haupt Pharma Berlin GmbH
- Inspection Date
- January 15, 2016
- Product Type
- Drugs
View Company Profile
ID · beed0aae-1434-4a66-a5e6-2b1d1c310233
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 959012
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Haupt Pharma Berlin GmbH
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Haupt Pharma Berlin GmbH
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.